• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物可定植微孔氟碳触觉(BIOKOP)人工角膜植入术在角膜移植失败高风险患者中的五年随访

Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.

作者信息

Alió J L, Mulet M E, Haroun H, Merayo J, Ruiz Moreno J M

机构信息

Vissum/Instituto Oftalmológico de Alicante, Avda de Denia s/n, Edificio Vissum, 03016 Alicante, Spain.

出版信息

Br J Ophthalmol. 2004 Dec;88(12):1585-9. doi: 10.1136/bjo.2004.046375.

DOI:10.1136/bjo.2004.046375
PMID:15550368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1772453/
Abstract

AIM

To study the anatomical and visual performance following implantation of a model of artificial cornea and to evaluate the postoperative long term complications.

METHODS

11 eyes of 11 patients with bilateral corneal blindness considered as potentially having high risk of failure of penetrating corneal keratoplasty were implanted with biocolonisable Kpro keratoprosthesis (BIOKOP I, FCI, Rantigny, France) in the period between January 1996 and May 1998. Only one eye was implanted in all patients and followed up for a period of 60 months. The visual outcome, anatomical and functional stability, complications, and the general performance of the keratoprosthesis were evaluated.

RESULTS

The keratoprosthesis (BIOKOP I) only 36.3% remained in position to date. In the patients' last visit five eyes (45.4%) were blind and one (9.0%) showed a slight improvement in the best corrected visual acuity (BCVA) in comparison to preoperative tests. Six eyes (54.5%) showed improved BCVA before having postoperative complications. Four eyes underwent replacement of a BIOKOP I Kpro with a BIOKOP II as a result of extrusion. The keratoprostheses remained anatomically in situ for a mean of 25.5 months and their functional performance period was limited to a mean of 22 months.

CONCLUSION

Corneal keratoprosthesis (BIOKOP I, II) does not provide a stable anatomical relation with the surrounding ocular structures. Its ability to restore vision is limited to a short postoperative period in eyes implanted with severe ocular surface disease.

摘要

目的

研究人工角膜模型植入后的解剖结构和视觉性能,并评估术后长期并发症。

方法

1996年1月至1998年5月期间,对11例双侧角膜盲且被认为穿透性角膜移植术失败风险较高的患者的11只眼植入了可生物定植的Kpro角膜假体(BIOKOP I,FCI,法国兰蒂尼)。所有患者仅植入一只眼,并随访60个月。评估视觉结果、解剖和功能稳定性、并发症以及角膜假体的总体性能。

结果

截至目前,角膜假体(BIOKOP I)仅36.3%仍在位。在患者的最后一次随访中,5只眼(45.4%)失明,1只眼(9.0%)与术前检查相比最佳矫正视力(BCVA)有轻微改善。6只眼(54.5%)在出现术后并发症前BCVA有所改善。4只眼因假体挤出而将BIOKOP I Kpro更换为BIOKOP II。角膜假体在解剖学上原位保留的平均时间为25.5个月,其功能发挥期平均限于22个月。

结论

角膜假体(BIOKOP I、II)与周围眼结构未形成稳定的解剖关系。在植入患有严重眼表疾病的眼中,其恢复视力的能力仅限于术后短期内。

相似文献

1
Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.生物可定植微孔氟碳触觉(BIOKOP)人工角膜植入术在角膜移植失败高风险患者中的五年随访
Br J Ophthalmol. 2004 Dec;88(12):1585-9. doi: 10.1136/bjo.2004.046375.
2
Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.新型角膜假体的设计与效果:满足终末期瘢痕性角膜盲的未满足需求。
Cornea. 2020 Apr;39(4):484-490. doi: 10.1097/ICO.0000000000002207.
3
[The Boston keratoprosthesis in the management of corneal blindness: Indications and limitations].[波士顿人工角膜在角膜盲治疗中的应用:适应证与局限性]
J Fr Ophtalmol. 2018 Sep;41(7):642-649. doi: 10.1016/j.jfo.2017.11.039. Epub 2018 Aug 28.
4
Boston type 1 keratoprosthesis for failed keratoplasty.用于角膜移植失败的波士顿1型人工角膜
Int Ophthalmol. 2016 Feb;36(1):73-78. doi: 10.1007/s10792-015-0078-2. Epub 2015 May 16.
5
The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.波士顿 II 型角膜假体:马萨诸塞州眼耳医院的经验。
Cornea. 2011 Dec;30(12):1298-303. doi: 10.1097/ICO.0b013e318215207c.
6
A Foldable Nonpenetrating Keratoprosthesis: Medium to Long-Term Clinical Results in Patients with Corneal Blindness due to Noninflammatory Anterior Cornea Disease.一种可折叠非穿透性角膜假体:非炎症性前角膜疾病导致角膜盲患者的中至长期临床结果。
Middle East Afr J Ophthalmol. 2020 Oct 30;27(3):150-155. doi: 10.4103/meajo.MEAJO_8_20. eCollection 2020 Jul-Sep.
7
Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.加州大学戴维斯分校波士顿 1 型角膜假体的长期视力结果和并发症。
Ophthalmology. 2011 Aug;118(8):1543-50. doi: 10.1016/j.ophtha.2010.12.032. Epub 2011 Mar 12.
8
The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.波士顿1型人工角膜作为初次穿透性角膜手术。
Br J Ophthalmol. 2015 Dec;99(12):1664-8. doi: 10.1136/bjophthalmol-2014-306161. Epub 2015 Jun 1.
9
Long-term outcomes of the MICOF keratoprosthesis surgery.MICOF 角膜假体手术的长期疗效。
Ocul Surf. 2021 Jul;21:178-185. doi: 10.1016/j.jtos.2021.06.005. Epub 2021 Jun 9.
10
Comparative study of penetrating keratoplasty and vitreoretinal surgery with Eckardt temporary keratoprosthesis in ocular trauma versus non-trauma patients.眼外伤与非眼外伤患者行 Eckardt 临时角膜移植术与玻璃体视网膜手术的对比研究。
Graefes Arch Clin Exp Ophthalmol. 2019 Nov;257(11):2547-2558. doi: 10.1007/s00417-019-04420-0. Epub 2019 Jul 30.

引用本文的文献

1
Biomimetic vs. Direct Approach to Deposit Hydroxyapatite on the Surface of Low Melting Point Polymers for Tissue Engineering.用于组织工程的在低熔点聚合物表面沉积羟基磷灰石的仿生法与直接法对比
Nanomaterials (Basel). 2020 Oct 29;10(11):2162. doi: 10.3390/nano10112162.
2
Fyodorov-Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts.费奥多罗夫-祖耶夫角膜假体植入术:多次角膜移植失败患者的长期疗效。
Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):93-101. doi: 10.1007/s00417-010-1493-8. Epub 2010 Aug 27.
3
Bioactive interpenetrating polymer network hydrogels that support corneal epithelial wound healing.支持角膜上皮伤口愈合的生物活性互穿聚合物网络水凝胶。
J Biomed Mater Res A. 2009 Jul;90(1):70-81. doi: 10.1002/jbm.a.32056.
4
Legeais BioKpro III keratoprosthesis implantation: long term results in seven patients.Legais BioKpro III人工角膜植入术:7例患者的长期结果
Br J Ophthalmol. 2006 Sep;90(9):1146-51. doi: 10.1136/bjo.2006.092510.

本文引用的文献

1
[Clinical application of keratoprosthesis for corneal opacity unsuitable for keratoplasty].
Zhonghua Yan Ke Za Zhi. 2003 Oct;39(10):578-81.
2
Keratoprosthesis; acrylic optical cylinder with supporting intralamellar plate.
Am J Ophthalmol. 1962 Aug;54:284-94.
3
Histopathology of explanted collar button keratoprostheses: a clinicopathologic correlation.
Cornea. 2003 Jul;22(5):424-8. doi: 10.1097/00003226-200307000-00007.
4
Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications.使用合成水凝胶角膜AlphaCor进行角膜置换:装置、初步结果及并发症
Eye (Lond). 2003 Apr;17(3):385-92. doi: 10.1038/sj.eye.6700333.
5
[Keratoprostheses. Clinical aspects].[人工角膜。临床方面]
Ophthalmologe. 2002 Jul;99(7):523-31. doi: 10.1007/s00347-002-0659-0.
6
Seoul-type keratoprosthesis: preliminary results of the first 7 human cases.
Arch Ophthalmol. 2002 Jun;120(6):761-6. doi: 10.1001/archopht.120.6.761.
7
Management of vitreoretinal complications in eyes with permanent keratoprosthesis.永久性角膜移植术后眼玻璃体视网膜并发症的处理
Arch Ophthalmol. 2002 May;120(5):559-66. doi: 10.1001/archopht.120.5.559.
8
The Aachen-keratoprosthesis--a flexible KPro that permits intraocular pressure measurement.
Int J Artif Organs. 2002 Mar;25(3):238-42. doi: 10.1177/039139880202500311.
9
The Chirila Keratoprosthesis: phase I human clinical trial.基里拉人工角膜:一期人体临床试验。
Ophthalmology. 2002 May;109(5):883-9. doi: 10.1016/s0161-6420(02)00958-2.
10
[Current researches in keratoprosthesis].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2002 Jan;19(1):112-6.